Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Coleman

Showing results (841-850 of 1,064) with videos related to

Pageof 107
Sort By:
British Journal of Cancer|March 2, 2013
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based studyS Walters, C Maringe, J Butler, et al.
Cell Death and Differentiation|October 18, 2014
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degenerationM Di Stefano, I Nascimento-Ferreira, G Orsomando, et al.
Nature Neuroscience|March 21, 2018
TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTDMatthew A White, Eosu Kim, Amanda Duffy, et al.
Elife|November 19, 2021
Enrichment of <i>SARM1</i> alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disordersJonathan Gilley, Oscar Jackson, Menelaos Pipis, et al.
Nature Neuroscience|June 7, 2018
Publisher Correction: TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTDMatthew A White, Eosu Kim, Amanda Duffy, et al.
Journal of the American Academy of Dermatology|January 31, 2006
A quality rating scale for aesthetic surgical proceduresMurad Alam, Jean DesJardin, Kenneth A Arndt, et al.
Lancet (London, England)|December 4, 2014
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)Claudia Allemani, Hannah K Weir, Helena Carreira, et al.
Lancet (London, England)|February 4, 2018
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesClaudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, et al.
Neuro-Oncology|March 19, 2021
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)Fabio Girardi, Brian Rous, Charles A Stiller, et al.
Japanese Journal of Clinical Oncology|March 20, 2026
Trends in net survival of patients with cutaneous melanoma in Japan, 2000-14 (CONCORD-3)Hiromi Sugiyama, Veronica Di Carlo, Melissa Matz, et al.
Pageof 107

Showing results (841-850 of 1,064) with videos related to

Sort By:
Pageof 107
British Journal of Cancer|March 2, 2013
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based studyS Walters, C Maringe, J Butler, et al.
Cell Death and Differentiation|October 18, 2014
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degenerationM Di Stefano, I Nascimento-Ferreira, G Orsomando, et al.
Nature Neuroscience|March 21, 2018
TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTDMatthew A White, Eosu Kim, Amanda Duffy, et al.
Elife|November 19, 2021
Enrichment of <i>SARM1</i> alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disordersJonathan Gilley, Oscar Jackson, Menelaos Pipis, et al.
Nature Neuroscience|June 7, 2018
Publisher Correction: TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTDMatthew A White, Eosu Kim, Amanda Duffy, et al.
Journal of the American Academy of Dermatology|January 31, 2006
A quality rating scale for aesthetic surgical proceduresMurad Alam, Jean DesJardin, Kenneth A Arndt, et al.
Lancet (London, England)|December 4, 2014
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)Claudia Allemani, Hannah K Weir, Helena Carreira, et al.
Lancet (London, England)|February 4, 2018
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countriesClaudia Allemani, Tomohiro Matsuda, Veronica Di Carlo, et al.
Neuro-Oncology|March 19, 2021
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)Fabio Girardi, Brian Rous, Charles A Stiller, et al.
Japanese Journal of Clinical Oncology|March 20, 2026
Trends in net survival of patients with cutaneous melanoma in Japan, 2000-14 (CONCORD-3)Hiromi Sugiyama, Veronica Di Carlo, Melissa Matz, et al.
Pageof 107